An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
Phase 1
Completed
- Conditions
- Bradycardia
- Interventions
- Drug: CARDIX-101A, CARDIX-101B, CARDIX-101C
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Cardix Therapeutics LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05117346
- Locations
- 🇺🇸
SpaceMed-X, San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath